Home/Filings/4/0001209191-21-020263
4//SEC Filing

TOMSICEK MICHAEL JOHN 4

Accession 0001209191-21-020263

CIK 0001674416other

Filed

Mar 11, 7:00 PM ET

Accepted

Mar 12, 5:50 PM ET

Size

11.9 KB

Accession

0001209191-21-020263

Insider Transaction Report

Form 4
Period: 2021-03-10
TOMSICEK MICHAEL JOHN
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Shares

    2021-03-10+2,8333,243 total
  • Award

    Stock Option (Right to Buy)

    2021-03-11+25,36025,360 total
    Exercise: $133.88Exp: 2031-03-11Common Shares (25,360 underlying)
  • Award

    Restricted Stock Units

    2021-03-11+9,0009,000 total
    Common Shares (9,000 underlying)
  • Tax Payment

    Common Shares

    2021-03-10$124.15/sh1,352$167,8511,891 total
Footnotes (5)
  • [F1]This restricted stock unit award was granted on March 10, 2020 with respect to 8,500 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
  • [F3]Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.
  • [F4]This option was granted on March 11, 2021 with respect to 25,360 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 11, 2021.
  • [F5]This restricted stock unit award was granted on March 11, 2021 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025.

Issuer

CRISPR Therapeutics AG

CIK 0001674416

Entity typeother

Related Parties

1
  • filerCIK 0001570392

Filing Metadata

Form type
4
Filed
Mar 11, 7:00 PM ET
Accepted
Mar 12, 5:50 PM ET
Size
11.9 KB